884494-99-9 Usage
Uses
Used in Pharmaceutical Industry:
3-AMINO-2,6-DIBROMO-5-FLUOROPYRIDINE is used as a chemical intermediate for the synthesis of various biologically active compounds. It plays a crucial role in the development of pharmaceutical drugs and agrochemicals, contributing to the creation of novel therapeutic agents and crop protection products.
Used in Medical Research:
In the field of medical research, 3-AMINO-2,6-DIBROMO-5-FLUOROPYRIDINE is utilized for the exploration of new drug candidates. Its unique structure and functional groups make it a valuable starting point for the design and synthesis of innovative therapeutic agents targeting a range of diseases.
Safety Considerations:
Due to its potential hazards, it is essential to handle 3-AMINO-2,6-DIBROMO-5-FLUOROPYRIDINE with care. Proper safety measures should be implemented during its synthesis, storage, and use to minimize risks and ensure the well-being of individuals involved in its production and application.
Check Digit Verification of cas no
The CAS Registry Mumber 884494-99-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,4,4,9 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 884494-99:
(8*8)+(7*8)+(6*4)+(5*4)+(4*9)+(3*4)+(2*9)+(1*9)=239
239 % 10 = 9
So 884494-99-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H3Br2FN2/c6-4-2(8)1-3(9)5(7)10-4/h1H,9H2
884494-99-9Relevant academic research and scientific papers
COMPOUND HAVING BET INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREFOR
-
, (2020/12/22)
The invention relates to the field of pharmaceutical chemistry. Specifically, the present invention relates to a series of BET (bromodomain and extra-terminal domain) inhibitors having a novel structure, particularly inhibitors targeting BRD4 (Bromodomain-containing protein 4), and a preparation method and use therefor. The structure thereof is shown in the following general formula (I). Said compounds or a stereoisomer, racemate, geometric isomer, tautomer, prodrug, hydrate, solvate, or crystal form thereof, or a pharmaceutically acceptable salt thereof, and the pharmaceutical compsosition thereof can be used for the treatment and/or prevention of related diseases mediated by bromodomain proteins.
